학술논문
Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype.
Document Type
Article
Author
Source
Subject
*LETTERS to the editor
*AZACITIDINE
*MYELOID leukemia
*LEUKEMIA treatment
*
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented in reponse to the article regarding the importance of azacitidine-lenalidomide therapy in the treatment of high-risk myelodysplasia or acute myeloid leukemia with complex karyotype.